Health Technology Assessment in Australia - PHAR9114

Faculty: Faculty of Medicine

School: School of Medical Sciences

Course Outline:

Campus: Sydney

Career: Postgraduate

Units of Credit: 6

EFTSL: 0.12500 (more info)

Indicative Contact Hours per Week: 10

CSS Contribution Charge: 2 (more info)

Tuition Fee: See Tuition Fee Schedule

Further Information: See Class Timetable

View course information for previous years.


PLEASE NOTE: This course has had a change of code and title - up to and including 2009, the course code was PHPH9114. Up to and including 2016, the course title was Pharmacoeconomics.

Health Technology Assessment focusses on the cost-benefit analysis of therapeutic interventions and the role of evidence-based medicine in determining the benefits of these interventions in health management. This course introduces students to the requirements for cost effectiveness for therapeutics and the role of evidence-based medicine in the decision-making process for these products. It covers pricing considerations for ensuring successful applications to the Pharmaceutical Benefits Advisory Committee (PBAC) for entry of medicines on the Pharmaceutical Benefits Scheme (PBS) in Australia. Students will also discuss the different economic methodologies used to determine the cost-benefit analysis of a medicine and when these different methodologies should be used.

Note: This course is one of two options for the compulsory Health Economics component for programmes 5371 and 9370.
Science students

Study Levels

UNSW Quick Links